Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Cell Banking Outsourcing Industry By 2029?

The expansion of the cell banking outsourcing market has accelerated significantly in the past few years. It is projected to increase from $11.19 billion in 2024 to $12.86 billion in 2025, with a compound annual growth rate (CAGR) of 15.0%. The increasing cases of chronic illnesses, the growth in government-initiated programs, regulatory help and guidelines, alongside the growth in banking services establishments are all key contributors to the historic period expansion.

The market size of cell banking outsourcing is projected to experience a significant surge in the coming years. It is anticipated to expand to “$21.65 billion by 2029, with a compound annual growth rate (CAGR) of 13.9%. The expansion during the forecast period is due to various factors such as increased usage of cellular products, heightened demand for monoclonal antibodies, greater application of stem cell therapies, the increasing elderly population, and a rising reliance on cell-based treatments. Key trends for the forecast period consist of product innovations, technological progression, investment in research and development, and partnerships between biotech firms and dedicated cell banking services.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Key Factors Are Fueling Growth In The Cell Banking Outsourcing Market?

The increase in chronic disease prevalence is likely to fuel the expansion of the cell banking outsourcing market. Chronic diseases are protracted ailments that usually evolve incrementally and remain for a prolonged duration. The escalating incidence of such diseases is associated with an amalgamation of several aspects, encompassing changes in lifestyle, ageing demographic, and genetic predisposition. Cell banking outsourcing is paramount in expediting research and development initiatives to tackle chronic illnesses by offering access to proficiency, resources, and facilities that might be lacking in-house. For example, as stated by the Department of the Treasury, an Australia-based national treasury and financial department, in July 2023, nearly half (46.6%) of Australians irrespective of age had at least one chronic disease in 2020–21, and nearly one in five (18.6%) had more than one chronic ailment. Consequently, the mounting burden of chronic diseases is steering the growth of the cell banking outsourcing market.

Which Segmentation Factors Are Critical In The Cell Banking Outsourcing Market Analysis?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Are The Dominant Trends Currently Seen In The Cell Banking Outsourcing Market?

Prominent players in the cell banking outsourcing market are prioritizing the creation of cutting-edge solutions including single-cell potency characterization platforms for accurate and comprehensive analysis of an individual cell’s potency. The single-cell potency characterization platform represents an advanced technology or collection of methods aimed at evaluating the potency and functionality of single cells within a cell population. For instance, in January 2024, Cellply Srl, a biotech firm located in Italy, introduced VivaCyte – its premier product, and a comprehensive single-cell potency characterization platform combining potency analysis and immunophenotyping to expedite cell therapy R&D. The VivaCyte platform is fully automated, standalone, and capable of single-cell resolution, designed to cut down on development time, expenses, and risk by rapidly and fully characterizing the intricate functionality and mechanisms of potential cellular immunotherapies. The platform allows for quick testing of multiple cell therapy options from diverse processing choices against various target tumor cells, it offers consistent immune cell and single-cell functional characterization in much less time than traditional analytical tools require.

Who Are The Dominant Players In The Cell Banking Outsourcing Market Today?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model